Society for Cardiovascular Angiography Interventions (SCAI)

The Society for Cardiovascular Angiography and Interventions (SCAI) represents interventional cardiology through education, advocacy, research, setting guidelines and quality patient care. SCAI provides thought leadership in cath lab procedures, new technology and policy.

RSS icon
Harry Lee Page, Jr., MD, a veteran cardiologist who helped pioneer many modern interventional techniques, died on August 11 after a long illness. He was 88 years old. SCAI

‘The end of an era’: Influential cardiologist, dead at 88, made a lasting impact

“We are so fortunate to have had fearless luminaries such as Harry Page at the helm of our profession,” SCAI President Sunil V. Rao, MD, said in a statement.

Cardiologist-backed bill focused on the heart health of South Asian Americans gains momentum

After successfully making it through the House, the new legislation is now headed to the Senate. 

Thumbnail

Cardiologists, radiologists join American Medical Association to speak out against ACA lawsuit

Yet another lawsuit is taking aim at the Affordable Care Act, and 61 U.S. medical organizations have joined forces to speak out.

Anita Asgar, MD, MSc, FSCAI, director, transcatheter valve therapy research at Montréal Heart Institute, discusses a textbook she co-edited with Jason Rogers, MD, on the transcatheter edge-to-edge repair (TEER) of the mitral valve.

VIDEO: SCAI publishes free how-to textbook on TEER procedures

Anita Asgar, MD, discusses a free textbook available online she co-edited on the transcatheter edge-to-edge repair (TEER) of the mitral valve. 

Thumbnail

Cardiologists push back on FDA’s thyroid monitoring/contrast media proposal

According to a new SCAI statement, the FDA's recommendation would result in "far-reaching consequences" across multiple specialties. 

Links to all the SCAI 2022 late-breaking clinical research

The Society for Cardiovascular Angiography and Interventions (SCAI) has announced its late-breaking study presentations at its 2022 Scientific Sessions. 

Early clinical evaluation of the Alleviant System to create no-implant interatrial shunts to treat heart failure patients with preserved and reduced ejection fraction (HFpEF and HFrEF) demonstrated procedural safety and feasibility with a promising efficacy signal through six months.

Key interventional cardiology takeaways from the SCAI 2022 conference

The key interventional cardiology takeaways from sessions presented at the Society for Cardiovascular Angiography and Interventions (SCAI) 2022 annual meeting.

TPV valves, CTO PCI and more: SCAI 2022 updates for interventional cardiologists

The first two days of SCAI 2022 were jam-packed with innovative technologies and late-breaking research.

Displaying 65 - 72 of 103

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.